セッション詳細
海外招聘講演2
「Dementia with Lewy Bodies: Recent Advances and Future Directions」
2026年11月14日(土) 9:50 〜 10:40
第1会場(つくば国際会議場 2F Leo Esaki メインホール)
座長：池田 学（大阪精神医療センター脳とこころの未来医療センター／大阪大学健康支援・相談センター）
[IL2]Dementia with Lewy Bodies: Recent Advances and Future Directions
John O'Brien
(Old Age Psychiatry, University of Cambridge, UK)
◆略歴
John O’Brien is Professor of Old Age Psychiatry in the Department of Psychiatry at the University of Cambridge, having previously been Professor of Old Age Psychiatry in Newcastle. He is also a National Institute for Health and Care Research (NIHR) Emeritus Senior Investigator, a Fellow of the UK Academy of Medical Sciences and former National Specialty Lead for Dementia. He is a member of national and international guideline and consensus groups, including those of the National Institute for Health and Care Excellence (NICE) and the European Stroke Association. He is a Steering Committee member of the European DLB Consortium and a member of the International Consortium for DLB Executive.
His research interests include the use of neuroimaging as a diagnostic and prognostic biomarker in dementia and the diagnosis and management of Lewy body and vascular dementias. He was Chief Investigator on the DIAMOND-Lewy Programme seeking to improve the diagnosis and management of Lewy body dementia.
(Old Age Psychiatry, University of Cambridge, UK)
◆略歴
John O’Brien is Professor of Old Age Psychiatry in the Department of Psychiatry at the University of Cambridge, having previously been Professor of Old Age Psychiatry in Newcastle. He is also a National Institute for Health and Care Research (NIHR) Emeritus Senior Investigator, a Fellow of the UK Academy of Medical Sciences and former National Specialty Lead for Dementia. He is a member of national and international guideline and consensus groups, including those of the National Institute for Health and Care Excellence (NICE) and the European Stroke Association. He is a Steering Committee member of the European DLB Consortium and a member of the International Consortium for DLB Executive.
His research interests include the use of neuroimaging as a diagnostic and prognostic biomarker in dementia and the diagnosis and management of Lewy body and vascular dementias. He was Chief Investigator on the DIAMOND-Lewy Programme seeking to improve the diagnosis and management of Lewy body dementia.